Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study.

T. Ellingsen, Kim Hørslev-Petersen, Merete Lund Hetland, P. Junker, Jan Pødenphanth, Mikkel Østergaard, K. Stengaard-Pedersen

    Original languageEnglish
    JournalArthritis & Rheumatism
    Volume64
    Issue number10 suppl.
    Pages (from-to)S181
    Number of pages1
    ISSN0004-3591
    Publication statusPublished - 2012

    Cite this